Minipress (prazosin) is licensed for hypertension, and FDA-approved generic prazosin hydrochloride capsules from several manufacturers now sit alongside the older Pfizer brand, which UK and US buyers have both seen go short of stock in recent years.
Minipress (prazosin hydrochloride), originated by Pfizer and marketed in the UK as Hypovase, is a short-acting alpha-1 adrenoceptor antagonist licensed for hypertension. M Care Exports is a merchant exporter: we source FDA-approved generic prazosin hydrochloride capsules through licensed Indian distribution and manufacturing channels and dispatch on quote, not from our own manufacturing.
Prazosin exporter and bulk supplier from India.
For hospital, wholesaler and MoH tender orders, M Care quotes prazosin against buyer specification: generic prazosin hydrochloride capsules (1 mg, 2 mg, 5 mg) or, where a market's registration and stock position allow it, the Pfizer-originated Hypovase tablet line, drawn from licensed WHO-GMP manufacturer lines on the M Care roster. Because prazosin's UK originator supply has been disrupted more than once and a first-dose syncope warning governs how a receiving pharmacy titrates new patients, we confirm strength mix and destination-market registration before dispatch, then align CTD/eCTD or country-specific dossier paperwork to the destination regulator's requirements.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Alpha-1 adrenoceptor antagonist antihypertensive, sourced and documented for export.
Prazosin is a selective, competitive alpha-1 adrenoceptor antagonist. It blocks postsynaptic alpha-1 receptors on vascular smooth muscle, relaxing both arterioles and veins and lowering peripheral vascular resistance, without the reflex tachycardia that older non-selective agents in the same broad antihypertensive family can trigger. It is dosed orally, not injected, and needs no reconstitution. The FDA label's indication is treatment of hypertension, to lower blood pressure and so reduce the risk of fatal and non-fatal cardiovascular events, used alone or combined with a diuretic or beta-blocker. The UK Hypovase SmPC licenses the same hypertension use plus congestive heart failure as adjunctive therapy, Raynaud's phenomenon, and the symptoms of benign prostatic hyperplasia; destination-country labelling should be checked against this before a tender quote is finalised, since not every market licenses the same additional indications. Prazosin is supplied as 1 mg, 2 mg and 5 mg capsules in the US Minipress and generic presentations, and as 500 microgram (0.5 mg) tablets under the UK Hypovase brand.
Active ingredient
prazosin hydrochloride. Alpha-1 adrenoceptor antagonist antihypertensive.
Forms and strengths
1 mg capsule; 2 mg capsule; 5 mg capsule.
Indications
Short-acting, selective alpha-1 adrenoceptor antagonist licensed for hypertension, relaxing vascular smooth muscle to lower peripheral resistance. Supplied from Indian WHO-GMP facilities as generic prazosin hydrochloride capsules to regulated and semi-regulated markets.
Administration
oral. Capsule (US) or tablet (UK), taken orally, first dose given at bedtime.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers for prazosin are hospital cardiology and general-medicine pharmacies managing resistant or secondary hypertension where an alpha-blocker adds to a diuretic or beta-blocker regimen, national and regional MoH tender desks running antihypertensive formulary lists, licensed pharmaceutical wholesalers and importers, and NGO or foundation procurement programmes supporting non-communicable-disease treatment access in markets where local registration is in place. Community mental-health and veterans'-health services in some destination markets also specify prazosin off-label for trauma-related nightmares, which buyers should flag separately since it is not an FDA- or MHRA-licensed indication.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on prazosin.
Prazosin carries a first-dose effect: a small proportion of patients respond with marked postural hypotension, dizziness or syncope within 30 to 90 minutes of the first capsule, so both the FDA and UK labelling call for a low starting dose (1 mg or 500 micrograms two or three times daily), given at bedtime, before any titration. Maintenance doses build slowly to a usual ceiling of 15 to 20 mg daily in divided doses, with some patients titrated to 40 mg. Because a treatment gap of even a few days can reset that first-dose risk, medicines reconciliation should flag any recent non-adherence before a dose is resumed at its prior level rather than restarted low. Concomitant PDE-5 inhibitor use (sildenafil, tadalafil) needs caution and dose separation, since both drug classes lower blood pressure independently and can cause additive hypotension. Intraoperative floppy iris syndrome is a recognised risk during cataract surgery in patients taking or previously exposed to alpha-1 blockers including prazosin, so the operating ophthalmologist needs advance notice regardless of whether the drug is stopped beforehand. Prazosin is not licensed for post-traumatic stress disorder nightmares, an off-label use with a mixed evidence base including a negative 2018 NEJM veterans trial, so any such prescribing should be flagged as outside the approved label when a formulary line is built.
The documentation pack a regulator actually asks for.
As an oral solid dosage form, prazosin travels on standard ambient-temperature logistics rather than the cold-chain lanes M Care validates for biologics and insulins; the UK SmPC specifies storage below 30 degrees Celsius with a 3-year shelf life, and buyers should expect similar ambient storage terms from any Indian WHO-GMP line quoted. Prazosin is not a controlled substance in any market M Care currently reviews, which keeps the documentation load to the standard non-scheduled generic file: batch-level certificate of analysis, CDSCO export documentation, and CTD or eCTD-format dossier support where the destination regulator requires local registration. Prazosin does not appear on the current WHO Model List of Essential Medicines, which lists newer agents such as amlodipine, enalapril, hydrochlorothiazide and bisoprolol as its recommended first-line antihypertensives, so tender desks should treat prazosin as a formulary-specific option rather than a WHO-EML first-line agent. On the brand-versus-generic question, Minipress in the US and Hypovase in the UK remain the Pfizer-originated products, while FDA-approved generic prazosin hydrochloride capsules are separately registered and marketed by multiple manufacturers, including Teva and Aurobindo, so buyers genuinely have a brand-or-generic choice; M Care quotes generic prazosin against the tender specification. UK buyers should also note that Pfizer's Hypovase supply has faced recent disruption, including a 500 microgram tablet shortage after the 1 mg tablet was discontinued, which formulary desks have cited as a reason to keep a secondary export source of generic prazosin on file.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside prazosin.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for prazosin.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Prazosin supply, the specific questions.
Does a generic version of Minipress exist?
Yes. FDA-approved generic prazosin hydrochloride capsules are registered and marketed in the US from several manufacturers, including Teva and Aurobindo, alongside the originator Minipress. Registration status for generic prazosin varies by destination country, so M Care checks local approval before quoting against a specific tender.
Can M Care supply Minipress or Hypovase to our market?
M Care sources FDA-approved generic prazosin hydrochloride capsules through licensed Indian distribution and manufacturing channels and dispatches against your import authorisation and destination-market registration status. Pfizer's own Hypovase brand has faced recurring UK supply disruptions, which is a live reason many formulary desks now specify generic prazosin as the primary tender line.
What strengths of prazosin does M Care supply?
1 mg, 2 mg and 5 mg capsules, matching the US Minipress and generic strengths. Tell us your dosing protocol and titration schedule and we quote the strength mix accordingly.
Why does prazosin need a low starting dose?
A small proportion of patients experience a first-dose effect: marked postural hypotension, dizziness or syncope within 30 to 90 minutes of the first capsule. Both the FDA and UK labelling require an initial low dose given at bedtime, with slow titration afterwards, and the same caution applies if a patient restarts prazosin after missing several days of doses.
Is prazosin on the WHO Essential Medicines List?
No. Prazosin does not appear on the current WHO Model List of Essential Medicines for hypertension, which lists agents such as amlodipine, enalapril, hydrochlorothiazide and bisoprolol as its recommended first-line options. Tender desks should specify prazosin as a formulary-specific antihypertensive rather than a WHO-EML first-line agent.
Does prazosin need cold-chain shipping?
No. It is an oral capsule stored below 30 degrees Celsius with a standard shelf life, so it moves on standard ambient logistics rather than the validated cold-chain lanes M Care uses for biologics and insulins.
What documentation does M Care provide with a prazosin shipment?
Batch-level certificate of analysis, CDSCO export documentation from the Indian side, and CTD/eCTD-aligned dossier support where the destination regulator requires local registration before import.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-09-13.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.